Appili Therapeutics Inc.
Appili Therapeutics Inc. (APLIF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · APLIF · as of Jun 15, 2026
Key Statistics
Explore Appili Therapeutics Inc. Data
aplif stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
aplif competitorsAPLIF
AAGH
ADXS
AGNPF
HESG
IBOGFStock Performance
Full HistoryAbout Appili Therapeutics Inc.
Appili Therapeutics Inc. founded in 2015 and headquartered in Halifax, Canada, is a biopharmaceutical company dedicated to sourcing and progressing innovative medical treatments to address critical u…
what is appili therapeutics inc. · aplif stock overview · appili therapeutics inc. company profile · who is appili therapeutics inc. ceo · aplif OTC · appili therapeutics inc. headquarters · appili therapeutics inc. business segments
About Stock Overview & Key Data
Appili Therapeutics Inc. (APLIF) is a Healthcare company in the Biotechnology industry, listed on OTC since Jan 8, 2021. As of the latest trading session, APLIF stock price is $0.01, with a market capitalization of $1.6M. The stock has returned -16.67% over the past 12 months and -32.43% year-to-date.
In fiscal year 2025, Appili Therapeutics Inc. reported revenue of $100443.00. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Appili Therapeutics Inc. (APLIF) stock price is $0.01. The stock is traded on OTC under the ticker symbol APLIF. The 52-week range is $0.01 – $0.03.